Patrick Schöffski

Address Department of General Medical Oncology
Laboratory of Experimental Oncology
University Hospitals Leuven
KU Leuven
Country

Belgium

Schoffski Patrick

Professor Schöffski heads the Department of General Medical Oncology and the Laboratory of Experimental Oncology at the University Hospitals Leuven, KU Leuven, Belgium.

His research interests include treatment of solid tumours and translational research aimed at the development of new therapeutic agents. He co-ordinates or works as an investigator on several clinical trials, ranging from Phase I – III, on a variety of tumour types, including thyroid cancer. He contributed significantly to the two recent pivotal trials in medullary thyroid carcinoma.

He is responsible for current prospective trials including entities such as sarcomas, urogenital and endocrine malignancies, and runs a number of non-disease specific Phase 1 trials.

Prof. Schöffski has been involved in registrational trials of antitumour agents in gastrointestinal stromal tumours and soft tissue sarcoma, and leads several sarcoma research projects for the Connective Tissue Cancers Network (CONTICANET), a Network of Excellence funded by the European Commission’s Sixth Framework Programme.

In addition to his roles at KU Leuven, Prof. Schöffski also served as Secretary-General of the Executive Committee and Board of the European Organization for Research and Treatment of Cancer (EORTC) and has been the Chairman of the Clinical Research Division of EORTC. He is member of the Board of Directors of the European Cancer Organisation (ECCO) and member of multiple scientific societies including the American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR), American Thyroid Association (ATA), European Society for Medical Oncology (ESMO), German Society of Haematology and Oncology (DGHO), Belgian Society for Medical Oncology (BSMO).

Prof. Schöffski gives scientific advice to pharmaceutical companies and health research-funding bodies and has published 180 peer-reviewed scientific articles.